Sandoz, Ratiopharm Infringe Oxycontin Patents: Court
The Court of Appeal of the Supreme Court of Judicature in London overturned in part a lower court ruling that had found two U.K. patents for the drug valid but not infringed. It rejected an appeal from the German generics claiming the patents were invalid, upholding a finding of validity.
The decision comes as Sandoz...
To view the full article, register now.